Biotech China 2014

Oncology: Memorial Sloan-Kettering Cancer Center

Total Score People Score Events Score
94 70 37
Date Event Presentation Speakers
April 28, 2014 Companion Diagnostics: From Biomarker Identification to Market Entry The Future of Academic Research towards Translation for Personalized Medicine Charles L Sawyers
May 31, 2013 ASCO Annual Meeting 2013 Multimodality Approaches to Achieving Tobacco Cessation in the Oncology Practice Jamie S. Ostroff
Optimizing the Role of Advanced Practice Professionals in Oncology Practice Dean Bajorin
Prostate Cancer Screening: Past, Present, and Future Peter T Scardino, Ethan M. Basch
Relating to Patients on a Humanistic or Spiritual Level: How Physicians Can Make a Difference (M01) Jimmie C Holland
More Mastectomies: Why? (C05) Monica Morrow
Multiplex Genetic Testing for Inherited Cancer Risk: Pros and Cons Mark Robson
Optimizing Locoregional Treatment in Early-Stage Breast Cancer Hiram S. Cody
Education Sessions Robert G Maki, Leonard Saltz
Education Sessions Ethan M. Basch
Education Sessions Kenneth Offit
Education Sessions Andrew David Zelenetz, Stuart M Lichtman, Sergio Giralt
Special Session Teresa Gilewski
April 6, 2013 AACR Annual Meetings CANCER EVOLUTION AND RESISTANCE Neal Rosen
Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Hans-Guido Wendel
Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY Jedd D. Wolchok, Margaret Callahan
Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Chris Sander
The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Douglas A. Levine
Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO James P Allison
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James A. Fagin
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY David B. Solit
Clinical Trials Based on Mutations versus Histology Charles L Sawyers
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Neal Rosen
Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Andrea Ventura
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY David C Lyden
Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA Victoria M. Richon
Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY Johanna A. Joyce
October 31, 2012 The 4th Annual Life Sciences Summit Translational Research Forum – Oncology: “Despite Progress, Cancer Still Remains a Major Health Burden” Clifford Hudis
October 18, 2012 Chicago International Breast Course and The Society for the Advancement of Women's Imaging Annual Meeting Advances in Gynecologic Imaging: Combining Morphology and Function Evis Sala
October 4, 2012 14th Annual Lynn Sage Breast Cancer Symposium Z11 One Year Later: Issues and Implementation Monica Morrow
Multidisciplinary Tumor Board: Case Reviews and Audience Response Monica Morrow
Radiation Alternatives in the Older Patient: Intraoperative, Short Course, PBI Alice Ho
Obesity, Inflammation and Breast Cancer Clifford Hudis
Optimizing Reconstructive Outcomes when PMRT is Necessary Babak Mehrara
September 13, 2012 International Society of Gastrointestinal Oncology Updates on Pathologic Classification and Grading of NETs David S. Klimstra
Chemotherapy and Radiation Therapy is Necessary Preoperative Therapy David H. Ilson
Session 1 | Esophageal/Gastric Cancer David H. Ilson
Welcome From the President David H. Ilson
April 27, 2012 2012 Annual Paris Melanoma Conference An update on ipilimumab combination studies Jedd D. Wolchok
February 22, 2012 The SRS/SBRT Scientific Meeting - 2012 SBRT and Other Therapeutic Approaches for Clinically Localized Prostate Cancer Michael J Zelefsky
May 18, 2011 SBI 10th Postgraduate Course High Risk Screening D. David Dershaw
Challenging Cases MRI (Audience Response System) Christopher E. Comstock
Cancer | The Patient’s Perspective Laura Liberman
Management After MR Biopsy Carol H. Lee
Updates in Imaging | Cases for the Experts D. David Dershaw
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Control of 3´UTR length by alternative cleavage and polyadenylation and its role in human cancer Christine Mayr
July 15, 2010 Breast Cancer: Current Controversies | New Horizons Lunch Served | Challenging Multidisciplinary Cases – Early Stage and Advanced Disease Monica Morrow
Can We Reverse the Trend Toward Bilateral Mastectomies? Monica Morrow
May 19, 2010 Towards Personalized Cancer Medicine Deconstructing Metastasis Joan Massagué
SESSION I: Biology (Processes Leading to Cancer) Joan Massagué
Closing Remarks Joan Massagué
Immune Checkpoint Blockade in Cancer Therapy James P Allison
April 30, 2010 UCSF Radiation Oncology Update: Management of Recurrent Disease Case Presentations and Panel Discussion Nancy Lee
Local Recurrence in the Nasopharynx and other Non-NP Head and Neck Sites Nancy Lee
HEAD AND NECK TUMORS Nancy Lee
Surgical Salvage for Recurrence after Radiotherapy James Eastham
February 19, 2010 Eighth International Symposium on Supportive Care in Oncology: Cancer Management in the Era of Targeted Agents Special Lecture: Integrative Approaches to Supportive Cancer Care Gary E. Deng
Management of Skin Rash and Other Cutaneous Toxicities Mario E. Lacouture
January 21, 2010 2010 DERMATOLOGY FOUNDATION CLINICAL SYMPOSIA: ADVANCES IN DERMATOLOGY III. Dermatological Toxicities of Targeted Agents Mario E. Lacouture
Dermatological Toxicities of EGFR-inhibitors Mario E. Lacouture
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Critical Review/Summary of Level of Evidence/Research Direction Simon Yeung
Session 3: Traditional Chinese Medicine Simon Yeung
November 2, 2009 Track 1: Seventh Annual RNAi for Screening Cellular Pathways and Targets Genome-wide siRNA Gain-of-Function Screen for Modulators of the miRNA Pathway Hakim Djaballah
October 16, 2009 Eighth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy Optimizing Adjuvant Chemotherapy Regimens for High-Risk Breast Cancer Andrew Seidman
Role of Anthracyclines in the Treatment of Early-Stage Breast Cancer Clifford A. Hudis
Controversies in Reconstruction Joseph J. Disa
Controversies in Surgery Hiram S. Cody
Controversies in Systemic Therapy Andrew Seidman
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Leonard Saltz
Treatment of Incurable Metatstatic Colorectal Cancer Leonard Saltz
Panel Discussion With Interactive Q/A Nabil Rizk
Sparing Esophagus in Patients with Esophageal Cancer Nabil Rizk
January 26, 2009 Biomarker Assay Development Biomarker Assay Development and Validation: An Epiphany for Drug Development and the Management of Patients with Cancer Martin Fleisher
January 26, 2009 Translational Cancer Medicine Biomarker Assay Development and Validation: An Epiphany for Drug Development and the Management of Patients with Cancer Martin Fleisher
January 21, 2009 Advances in Prostate Cancer Research SESSION 4: TECHNOLOGIES / IMAGING Howard Scher
SESSION 7: THERAPEUTICS / IMMUNOTHERAPY James P Allison
January 5, 2009 High Content Analysis Implementation of HCA for Chemical Screening: Applications to Anti-Viral and Stem Cell Modulators Discovery Hakim Djaballah
November 23, 2008 Advanced Technology in Radiation Oncology Phase II Trial Of Sunitinib (SU011248) In Patients With Recurrent Or Inoperable Meningioma. Thomas J. Kelly,
November 20, 2008 The 13th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology Overcoming Stem Cell Resistance Eric C Holland
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Split Session B: Integrative Oncology for Survivors: Complementary Therapies, Herbs and Other Non-Prescription Agents Barrie R. Cassileth
October 22, 2008 HDAC Inhibitors: Targeting Oncology and Beyond Progress in the Development of Vorinostat Victoria M. Richon
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Plenary session 5 Molecular targets-state of the science C David M Spriggs
June 27, 2008 American Society of Clinical Oncology General Session III: Gastrointestinal (Colorectal) Cancer David P Kelsen
General Session X: Gynecologic Cancer David M Spriggs
May 30, 2008 ASCO Annual'08 Meeting general oncology sessions-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
general oncology sessions-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
breast cancer-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
central nervous system tumors-- The Growing Challenge of CNS Metastases: New Therapeutic Approaches Lauren E. Abrey
clinical trials-- Patient-Reported Outcomes in Oncology Ethan M. Basch
gynecologic cancer-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
head and neck cancer-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
health services research-- Patient-Reported Outcomes in Oncology Ethan M. Basch
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
lymphoma and plasma cell disorders-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
patient and survivor care-- Patient-Reported Outcomes in Oncology Ethan M. Basch
patient and survivor care-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
professional development-- Integrating the Humanistic and Scientific Aspects of Patient Care: The Perspective of Seasoned Surgical, Medical, Pediatric, and Radiation Oncologists Teresa Gilewski
sarcoma/bone and soft tissue cancers-- Benefit of Multimodality Management of Advanced Sarcoma: Why the Medical Oncologist Should Not Work Alone Murray F. Brennan
tumor biology-- Physiologic Response Imaging in Head and Neck Cancer Clifton Ling
meet the professor sessions-- Chemotherapy-Induced Cognitive Impairment (M06) Tim A Ahles
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11A) Andrew David Zelenetz
clinical problems in oncology-- Prognosis, Risk Stratification, and Treatment of Diffuse Large B-Cell Lymphoma: Incorporation of New Imaging Modalities and Molecular Markers (CPO11B) Andrew David Zelenetz
February 19, 2008 Screening Europe Track A Novel High-Throughput Platforms Hakim Djaballah
Track A High Content Screening of Human ES Cells Using Laser Scanning Confocal Microscopy Hakim Djaballah
January 18, 2008 Translational Research Program Stem Cell Symposium RADIATION RESISTANCE/TARGETING STEM CELL PATHWAYS Dolores Hambardzumyan
November 15, 2007 2007 Fourth International Conference Introduction/Welcome Carol Aghajanian
1. Integrative Oncology Education Models Panel Gary E. Deng
1. Integrative Oncology Education Models Panel Gary E. Deng
The Patient’s Perspective Panel Carol Aghajanian
Poster Review Gary E. Deng
Tumor Board — Integrative Case Studies Carol Aghajanian
November 6, 2007 Chemotherapy Foundation Symposium XXV NEW AGENTS IN OVARIAN CANCR Carol Aghajanian
NEW DEVELOPMENTS IN TARGETED THERAPY David G. Pfister
ANTI-HER2 THERAPY: BEYOND TRASTUZUMAB Clifford A. Hudis
Dinner & Special Presentation Educational Grant: Genomic Health Andrew Seidman
ANTI-TUMOR ACTIVITY OF ABIRATERONE ACETATE IN CASTRATION-RESISTANT PROSTATE CANCER Daniel Danila
TARGETED THERAPIES – THE NEXT WAVE Charles L Sawyers
INTEGRATIVE MEDICINE: WHAT IT IS AND HOW IT HELPS CANCER CARE Gary E. Deng
October 20, 2007 Fourth Annual Fall Oncology Conference The Evolution of Bladder Cancer Treatment Dean Bajorin
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) OVERCOMING THE CHALLENGES: ADVANCED HDAC INHIBITORS (08:30-11:10) Paul A. Marks
OVERCOMING THE CHALLENGES - ADVANCED HDAC INHIBITORS: Chairperson’s Remarks (08:30-08:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Histone Deacetylase Inhibitors: Molecular Mechanism of Action (11:10-11:40) Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Howard Scher, Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Howard Scher, Paul A. Marks
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Chairperson’s Remarks (13:10-14:20) Paul A. Marks
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.